Technology
Kenya-based digital drug store MYDAWA has actually partnered with Endless Health to establish a digital-first design for high blood pressure and diabetes care, among 4 brand-new healthtech offers revealed at Investing in Innovation Africa‘s (i3)4th yearly Access to Markets occasion in Kigali.
The collaboration will co-design, test and record a design for providing persistent illness care to low- and middle-income clients through personal drug stores in East Africa.
Established in collaboration with Ariadne Labs, the effort will construct a proof base around the capability of personal drug stores to supply quality high blood pressure and diabetes care while enhancing gain access to for clients in their neighborhoods.
MYDAWA is likewise partnering with Turn.io, a WhatsApp-based client engagement platform, to make interaction with clients much easier and more available.
“Chronic illness care in East Africa is being provided through personal drug stores whether the system prepares for it or not,” stated Rubayat Khan, Director of Health Programs at Endless. “What is missing out on is proof about whether that channel can provide quality, not simply benefit.”
MYDAWA Group COO Priscilla Muhiu stated personal drug stores stay an essential very first point of take care of individuals coping with high blood pressure, diabetes and other persistent illness.
“This collaboration provides us a chance to make gain access to more economical and enhance care shipment for clients in their own neighborhoods,” Muhiu stated.
The MYDAWA collaboration was revealed together with 3 other arrangements including African healthtech business, banks, pharmaceutical business and regulators.
Tanzanian healthtech business Dawa Mkononi signed a working-capital contract with NMB Bank to extend interest-free credit to drug stores, drug stores and health centers throughout Tanzania.
The funding will be provided through Dawa Mkononi’s exclusive credit-scoring engine. The business states it has actually currently helped with more than $6 million in funding to frontline health centers, with a 0.3% non-performing rate.
Pharmaceutical supply-chain business Meditect has actually gotten financial obligation funding from Boehringer Ingelheim to broaden access to budget-friendly and genuine medications throughout Sub-Saharan Africa.
The funding will support Meditect’s growth into brand-new and current markets while assisting the business digitize pharmaceutical supply chains.
Boehringer Ingelheim Associate Director Aditya Peri stated reinforcing relied on pharmaceutical supply chains might assist enhance access to genuine medications and resolve the difficulty of fake and substandard items throughout the area.
In Nigeria, healthtech business Sproxil signed a Memorandum of Collaboration with the Pharmacy Council of Nigeria (PCN) to support drug store guideline through digital and expert system systems.
The cooperation will cover the National Electronic Pharmacy Platform, oversight of online pharmaceutical sales, digitization of PCN’s field audit workflow and broadened shipment of necessary continuing expert advancement for pharmacists.
PCN will keep complete regulative authority, while Sproxil will offer the innovation and information facilities.
The 4 contracts contribute to i3’s growing record of linking African healthtech business with industrial and institutional partners.
According to i3, its Access to Markets program has actually assisted in more than 760 bespoke intros, leading to 165 collaborations, pilots and memorandums of comprehending valued at more than $19 million.
Since April 2026, i3 innovators had actually served more than 6.85 million clients and tracked, secured or dispersed more than 209 million health items throughout Africa.
This year’s Access to Markets occasion combined 20 African health innovators and 57 international and local market gamers, consisting of Gavi, Johnson & & Johnson, Pfizer, BillionScale Health, AMREF and numerous federal government organizations.
The getting involved innovators consisted of Chefaa, Dawa Mkononi, Meditect, mPharma, MYDAWA, Sproxil and Zuri Health.
Together, the business are broadening client gain access to and pharmaceutical security through 3,500 health centers throughout 19 African nations.
“African innovators are improving health care shipment throughout the area, with options created to resolve regional spaces and reach the neighborhoods and clients who require them most,” stated Oladunni Lawal, Investing in Innovation Lead.
“Through Access to Markets, we are bringing local and worldwide partners more detailed to these companies, opening industrial chances that allow their developments to provide higher health effect.”
Access to Markets is i3’s flagship effort for linking African healthtech business with local and international health companies and market gamers, with a concentrate on industrial collaborations, market gain access to and scaling in your area established health care services.
i3 is supported by the Gates Foundation, MSD, Cencora, Endless Health, HELP Logistics, Sanofi and Boehringer Ingelheim and carried out by Salient Advisory and the Solina Centre for International Development and Research (SCIDaR).
Discover more from PMN S.P.O.R.T.S - A PRIME MEDIA NETWORK BRAND
Subscribe to get the latest posts sent to your email.
